INTERNATIONAL MENTAL HEALTH NETWORK, LTD.
P.O. Box 578
Poway, CA 92074-0578
Phone: (858) 486-9745
Fax: (858) 486-9760
E-mail: nac01@juno.com
A package of 10 test booklets and 50 answer sheets
available for $25 from IMH-Network: (858) 486-9745
Test Description
Return to the Index
=============================================================================
S A M P L E P R O F I L E
=============================================================================
BECK DEPRESSION INVENTORY INTERPRETIVE PROFILE
International Mental Health Network, Ltd.
TC: 7177
FACILITY ID: 031
PATIENT ID: 0311234
SOCIAL SECURITY NUMBER: 123-45-6789
LAST NAME: John
FIRST NAME: Doe
GENDER: Male
AGE: 32
RACE: White
HIGHEST GRADE COMPLETED: 13
MARITAL STATUS: No Data
OCCUPATION: Mail clerk
CURRENT EMPLOYMENT STATUS: Unemployed
INPATIENT/OUTPATIENT: Outpatient
NUMBER OF INPATIENT ADMISSIONS: 2
NUMBER OF OUTPATIENT ADMISSIONS: 4
DATE OF LAST DISCHARGE: / /
NUMBER OF YEARS OF ALCOHOL USE: 8
NUMBER OF YEARS OF DRUG USE: 3
SUBSTANCES USED LAST 2 YEARS: Marijuana, Heroin,
Cocaine, Alcohol
SOURCE OF REFERRAL: Physician
FINANCIAL CLASS: HMO
DATE OF LAST PHYSICAL EXAM: / /
ADMISSION DATE: 11/09/1997
DATE OF TESTING: 11/10/1997
BECK SCORE: 22
____________________________________________________________________________
This clinical profile is a confidential assessment report intended for use
by professional staff only. Its purpose is to provide clinicians with a
comprehensive clinical picture of each patient under their care, and to help
maximize therapeutic effectiveness through careful assessment, treatment
planning, relapse prevention, and aftercare. Recommendations made in this
profile do not imply that existing clinical approaches should be replaced or
modified. Their intent is to further promote individualization of patient
treatment planning, multidisciplinary approach to treatment of each patient,
patient's participation in own recovery process, and continuous monitoring
and reassessment of the therapeutic process for mutual benefit of both the
patient and clinical staff. Statements in this profile are hypotheses for
further consideration in combination with other clinical factors utilized
in therapy. This profile is intended for use by a multidisciplinary clinical
team.
____________________________________________________________________________
________________________________ _______________ ______________
Reviewing Professional Title Date
_______________________________________________________________________________
Patient Id: 0311234 11/10/1997
PROFILE INTERPRETATION
This scale range indicates moderate to high levels of clinical depression.
Somatic complaints are likely to occur and should be given full clinical
consideration to rule out possibility of organic etiology.
Suicidal ideation and possibility of auto-destructive behaviors
should be given full clinical attention with appropriate preventive
measures taken. Psychopharmacology should not be ruled out.
Some of clinical characteristics of patients with this type of profile
which may be manifested during the course of therapeutic interaction are:
- a lifestyle of learned helplessness,
- frequent utilization of health care resources with low therapeutic
effectiveness,
- frequent anxiety without apparent etiology,
- indifference about decreased energy level and frequent fatigability,
- behaviors indicating apathy toward self and others, dependence in and
acceptance of domination by others, allowing others to make even basic
decision regarding personal welfare, life-style, occupation, living
accommodations, nutrition, monetary issues, hygiene, etc.,
- illness-related regimen,
- patterns of isolation,
- behavioral manifestations of withdrawal such as turning away from
speaker, closing of eyes, lack of eye contact, shrugging of shoulders,
- sleep disturbances,
- lack of involvement or interest in significant others such as immediate
family, long-term friends, etc.,
- decreased willingness and ability to make decisions,
- possibility of genetic factors of depression and major affective disorders
and substance abuse among first-line relatives,
- family history of endocrine and/or metabolic disorders,
- history of suicidal ideation,
- hopelessness and a sense of a loss of purpose in life,
- loss of appetite,
- decrease in mood fluctuations during wake cycle,
- decline in appearance and self-care,
- degree of emotional and cognitive ambivalence,
- mood elevations, or sudden appearance of tranquility and peace along
with some increase in energy,
- prevalence of unrealistic belief systems,
- inability to apply problem-solving strategies,
- lack of effective coping skills,
- frequent failure to distinguish between external and internal stressors,
- manifestation of behaviors which may be precursors to self-destructive
acts such as gestures, threats, giving away personal possessions, making
of a will, etc.
- delusional though content, persecutory ideation,
- signs of collapse of the available support system,
- neglect of maintenance of nutritional needs,
- recent body weight issues such as significant weight gain or loss,
- neglect of personal hygiene, self-care, and appearance,
- neglect of medication regimens (when applicable),
- attempt at self-medication with non-prescription, illicit drugs,
and/or substance use/abuse,
- resistance to engage in therapeutic alliance.
_______________________________________________________________________________
Patient Id: 0311234 11/10/1997
MOOD AND AFFECT SYMPTOMS
The following is a spectrum of mood and affect symptoms which may be
specific to this profile type. Clinicians should also document and monitor
any additional mood and affect symptoms which may arise during the course of
treatment.
- Anxiety, worry, fear ............................................ ____
- Blunted affect .................................................. ____
- Emotional reactivity ............................................ ____
- Episodes of moderate depression and apathy ...................... ____
- Vegetative depressive features .................................. ____
- Low emotional adjustment ........................................ ____
- Emotional inertness ............................................. ____
- Range of vulnerabilities ........................................ ____
- Emotional fragility ............................................. ____
- Poor psychological health ....................................... ____
- Self-alienation ................................................. ____
- Naivete ......................................................... ____
- Sensitivity ..................................................... ____
- Brooding ........................................................ ____
- Frequency of painful affect states .............................. ____
- Highly subjective experience of the disease process ............. ____
- Poor ego strength ............................................... ____
- Ego constriction ................................................ ____
- Obsessionality .................................................. ____
- Occasional feelings of derealization ............................ ____
- Diminished interest in daily activities ......................... ____
- Lack of positive moods .......................................... ____
- Patterns of comorbidity between Axis I and Axis II disorders .... ____
- Long term course of disorder and comorbidity .................... ____
- Event-environment induced morbidity ............................. ____
- Low energy and increased fatigability ........................... ____
- Lassitude, malaise .............................................. ____
- Absence of adiurnal variation in mood and energy ................ ____
- Lack of assertiveness, indecisiveness ........................... ____
- Lack of ability to relax ........................................ ____
- Loss of reactivity to pleasant stimuli .......................... ____
- Diminished self-esteem .......................................... ____
- Feelings of worthlessness and hopelessness ...................... ____
- Introversion, shyness, social phobia ............................ ____
- Feelings of alienation and isolation ............................ ____
- Reliance on introspective cues .................................. ____
- Augmentation of perception of environmental stressors ........... ____
- Somatization of anxiety ......................................... ____
- Lack of permanent relief from somatic symptoms .................. ____
- Depressive episodes as a reaction to pain exarcebation .......... ____
- Psychological adaptation to pain via mood disorders ............. ____
- Psychological adaptation to pain ................................ ____
- Degree of discomfort expected ................................... ____
- Temporal contiguity referenced through process of illness/pain .. ____
- External locus of control ....................................... ____
- Sense of self-worth extrinsically contingent .................... ____
- Lack of specific symptoms as precipitating factors .............. ____
- Low need to succeed at the time of admission .................... ____
_______________________________________________________________________________
Patient Id: 0311234 11/10/1997
- Precipitation of relapse ........................................ ____
- Emotional augmentation during early recovery .................... ____
- Strong need for affection ....................................... ____
- Increased sensitivity to disapproval and criticism by others .... ____
- Overconcern with acceptance of authenticity
of own symptoms by others ....................................... ____
- Persistent need for excessive advice
and reassurance from others ..................................... ____
- Lack of immediate relief from distress even when stressors
are neutralized ................................................. ____
- Disturbance in sleep patterns ................................... ____
- Insomnia, hypersomnia, sleep inefficacy ......................... ____
- Exarcebation of psychiatric and somatic symptoms
with substance withdrawal ....................................... ____
- Lack of long range improvement in well-being .................... ____
- Poor psychological health ....................................... ____
- Persistent lack of sexual excitement ............................ ____
- No erotic sensations ............................................ ____
- Impotence ....................................................... ____
- Lack of positive external emotional stimulation ................. ____
- Reduced ability to speak of emotions (alexithymia) .............. ____
- Chronic stress from environment, family, vocation ............... ____
- Inability to tolerate negative affect ........................... ____
- Sense of internal conflict ...................................... ____
- Alexithymia ..................................................... ____
- Resistance to adopting a psychological view
of the somatic symptoms ......................................... ____
- Emotion-focused wishful thinking ................................ ____
OTHER:
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_______________________________________________________________________________
Patient Id: 0311234 11/10/1997
BEHAVIOR SYMPTOMS
The following is a spectrum of behavior symptoms which may be specific
to this profile type. All symptoms which are reported and observed should be
documented and monitored at regular intervals. Additional behavioral
symptoms which may arise during the course of treatment should also be
documented.
- Procrastination ................................................. ____
- Tendency toward indecisiveness and avoidance of responsibilities ____
- Difficulty initiating projects & independent actions ............ ____
- Stressful interpersonal relationship(s).......................... ____
- Avoidance of focused treatment and confrontation modalities ..... ____
- Possibility of substance use/ abuse ............................. ____
- Seeking reassurance, acceptance by others ....................... ____
- Occasional avoidance and displacement of responsibility ......... ____
- Diffusion of personal goals and self-imposed limitations ........ ____
- Dissatisfaction or change in role or relationship ............... ____
- Recent loss/dissolution of intimate relationships ............... ____
- Occasional preference for isolation and solitude,
- Claims that social interactions bring unsatisfactory results .... ____
- Social introversion and drifting ................................ ____
- Preference for passive participation in conversations
- Expressed and noticed discomfort in social interactions ......... ____
- Noticeable decrease in recreational orientation and skills ...... ____
- Patterns of somatization ........................................ ____
- Lack of diversionary activities ................................. ____
- History of unsatisfactory relationships ......................... ____
- Emotional-focused coping and avoidance .......................... ____
- Mild deregulation of food intake ................................ ____
- Neglect of health practices ..................................... ____
OTHER:
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
_________________________________________________________________ ____
___________________________ ________________________________
DATE CLINICAL STAFF